The CHMP's opinion is based on late-stage study data, which show that treatment with JNJ's combo drug reduces the risk of ...

“90 per cent of patients that have oral cavity cancer are 50 or older,” Dr Slaughter said ... s cancer but genetic testing is ...

Phase 2 CLOVER-WaM pivotal study data selected for oral presentation at 66th Annual American Society of Hematology Meeting ...

Phase 2 CLOVER-WaM pivotal study data selected for oral presentation at 66th Annual American Society of Hematology Meeting and Exposition Raised approximately $19.4 million with potential to raise up ...

ORLADEYO ® (berotralstat) is the first and only oral therapy designed specifically to prevent attacks of hereditary ...

Nanoform Finland Plc. November 18, 2024. 08:10 a.m. Finnish time / 07:10 a.m. Swedish time. Nanoform Q3 2024 report: Record number of new projects signed. A ...

Revenue growth is back and is expected to accelerate in coming quarters ... the current formulation of these blockbuster medicines - for treatment of prostate cancer - has been an amorphous solid ...

These topline results will be presented on November 19 in a late-breaking oral presentation at the American Association ... subcutaneous injection of a long-acting variant of human fibroblast growth ...

Cancer Daily Horoscope Today, November 18, 2024 to know your astrological predictions. Shower love on the partner and keep ...

Plus, the University of Rhode Island landed a $65 million bequest for STEM scholarships, and Craigslist founder Craig Newmark gave $25 million to help U.S. veterans and their families.

NetSPI, the leader in proactive cybersecurity solutions, today announced that Caroline Japic has joined the company as Chief Marketing Officer. With more than 15 years of experience leading marketing ...

TOYO Co., Ltd ("TOYO" or the "Company"), a solar solution company, today provided an update on its anticipated business performance for the full year 2024, and announced preliminary guidance for 2025, ...